Skip to main page content

• HOME
• Current Issue
• Archive
• Alerts
• About ASM
• Contact us
• Tech Support
• Journals.ASM.org

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Blomqvist, S. Articles by Roivainen, M. Search for Related Content PubMed PubMed Citation Articles by Blomqvist, S. Articles by Roivainen, M.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, July 2008, p. 2410-2413, Vol. 46, No. 7
0095-1137/08/$08.00+0     doi:10.1128/JCM.00313-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Eight Years of Experience with Molecular Identification of Human Enteroviruses

Soile Blomqvist,^* Anja Paananen, Carita Savolainen-Kopra, Tapani Hovi, and Merja Roivainen

Enterovirus Laboratory, Department of Viral Diseases and Immunology, National Public Health Institute (KTL), Helsinki, Finland

Received 14 February 2008/ Returned for modification 25 March 2008/ Accepted 24 April 2008

Top ABSTRACT TEXT REFERENCES

 
We have successfully typed 1,121 human enterovirus (HEV) isolates during the last 8 years by adapting partial VP1 sequencing to routine identification of HEV isolated from diverse clinical and environmental specimens. The isolates include 48 of the 59 traditional nonpoliovirus HEV serotypes and members of 8 newly discovered types, which would have remained untypeable by neutralization using the conventional cross-sectional pools of antisera.

Top ABSTRACT TEXT REFERENCES

 
Human enteroviruses (HEV) (family Picornaviridae) are small single-stranded RNA viruses that are grouped into four species, HEV-A, HEV-B, HEV-C, and HEV-D, by molecular characteristics. These species comprise altogether 62 antigenically distinct serotypes and at least 30 additional recently described genetically distinguishable types (18) (http://www.picornaviridae.com/enterovirus/enterovirus.htm). The identification of HEV types is essential in studies associating the HEV types with certain diseases, and it traditionally includes isolation of the virus in susceptible cell lines followed by neutralization either with type-specific antisera or with intersecting pools of antisera. The neutralization assay itself is laborious and time-consuming and may be further complicated by the aggregation of virus particles or by the existence of virus mixtures. Besides, the identification by neutralization is limited to only those serotypes against which potent monotypic antisera are available, while some of the currently circulating HEV strains with significant antigenic drifting and, especially, the new HEV types remain unidentified.

During the last decade, a variety of molecular technique-based methods have been developed for the identification of HEV types (e.g., see references 1, 3, 4, 6, 9, and 12). The sequencing of the (partial) VP1 capsid protein coding region, which is based on the existence of the most prominent serotype-specific immunogenic epitopes in VP1 leading to an absolute correlation between the VP1 sequence and the serotype (11), has been chosen for HEV identification in many laboratories (7, 10, 13, 14). Alternatively, molecular typing may include sequencing of coding regions for other capsid proteins (6, 9), whereas typing by sequencing the nontranslating genomic segments or regions coding for the nonstructural proteins is not widely used because of the discordant phylogeny due to the frequent intraspecies recombination in these regions (15).

The partial VP1 sequencing method described by Oberste et al. (12) was introduced to our laboratory in 1999 and used alternatively with the neutralization assay during the years 2000 to 2003 and since then exclusively. At the beginning, a part of the isolates were typed by both methods with 100% congruity (Table 1). Sixty percent of the viruses typed during the 8-year study period were originally isolated in Finland, and these included HEV from the environmental surveillance of polioviruses and clinical HEV isolates sent to the national enterovirus reference laboratory from other Finnish laboratories. The rest of the molecularly typed isolates were received as untypeable nonpolio enteroviruses (NPEV) from a number of National Polio Laboratories of the WHO Polio Laboratory Network supporting the Global Poliovirus Eradication Initiative. Altogether, 45% of the HEV isolates originated from environmental samples and 55% from a variety of clinical specimens, e.g., stool, skin or mouth vesicles, and nasopharyngeal swaps. The cell lines used in isolation included human rhabdomyosarcoma (RD), human colorectal adenocarcinoma (CaCo-2), human lung carcinoma (A549), human larynx epidermoid carcinoma (Hep-2C), human cervical carcinoma (HeLa), human fetal fibroblast (HFF), the green monkey kidney cell lines GMK, Vero, and LLC, and the recombinant mouse L cells expressing the human poliovirus receptor (L20B).

View this table: [in this window] [in a new window]

TABLE 1. Numbers of HEV isolates typed by partial VP1 sequencing or concurrently by neutralization during the years 2000 to 2007

RNA was extracted from 100 µl of the infected cell cultures by commercial procedures (RNeasy Total RNA kit [Qiagen GmbH, Hilden, Germany] or E.Z.N.A. Total RNA kit [Omega Bio-Tek Inc., Doraville, GA]) according to the manufacturer's instructions. One microliter of RNA was used in a single-tube reverse transcription (RT)-PCR assay. During the first 2 years of the study, two distinct regions of VP1 were amplified with two sets of primers as described in reference 12. Later on, the RT-PCR was first performed with a single set of primers only, forward and reverse primers 292 and 222, respectively (13). The alternative primers 040, 011, and 012 were used with 8.1% of the isolates, because a very small amount or no amplicon was obtained with the two primary primers or because of the poor quality of the first sequences. The RT-PCR products were analyzed using electrophoresis in a 2% agarose gel, and the amplicons were purified with commercial reagents (Qiagen Gmbh, Hilden, Germany) before use in sequencing (ABI Prism BigDye terminator cycle sequencing; Applied Biosystems). The quality of the electropherograms was examined using the Vector NTI Advance software program (Invitrogen) and the sequences compared to the sequence database in GenBank by BLAST. For an acceptable result, the length of the compared sequence had to be more than 100 nucleotides. The sequences that had more than 75% nucleotide identity with the query sequence determined the type of the isolate.

Altogether, 1,121 HEV isolates were molecularly typed during the reported 8-year period. The isolates comprised representatives of each of the four HEV species: 70.4% were members of HEV-B, 16.6% members of HEV-A, 12.1% members of HEV-C, and 0.9% members of HEV-D, respectively. The frequency distribution of the 59 "classical" NPEV serotypes is shown in Fig. 1. The five most common serotypes identified were echoviruses 11 and 6 and coxsackievirus (CV) A24, CV-B5, and CV-B4. Due to the incoherency of the isolate collection, this frequency distribution may not directly reflect the distribution of NPEV in Finland or other countries in the study region. However, four of the five most common serotypes (echoviruses 6 and 11, CV-B4, and CV-B5) were also among the most abundant serotypes isolated from sewage or patients in Finland during the years 1971 to 1992 (5), and they were also among the 10 most frequently reported serotypes in the United States in 1970 to 2005 (8). The most commonly reported NPEV in the United States, echovirus 9 (8), was infrequently found in Finland during this study period and during the previous study years 1971 to 1992 (5). The only HEV-C serotype that was common in the studied NPEV collection was CV-A24. The CV-A24 strains were isolated mainly from stool specimens from children who had immigrated to Finland and could most likely be regarded as importations rather than evidence of endemic circulation of CV-A24 in Finland. Eleven of the fifty-nine NPEV serotypes remained undetected. The lack of these types in the HEV isolate collection may be due to their poor propagation in cell lines used or their infrequent circulation in the catchment population. The isolates of the genetically characterized "newer" types EV-73 to EV-102 are shown in Table 2. Some isolates had less than 70% partial VP1 nucleotide identity to any sequence in the GenBank and were regarded as untypeable and supposed to represent new enterovirus types. The complete VP1 sequences of three new HEV candidates were sent to the Picornavirus Study Group, assigned a candidate prototype number (EV-94, EV-96, and EV-97), and subsequently characterized further (16, 17).

View larger version (15K): [in this window] [in a new window]

FIG. 1. The numbers of different "traditional" nonpoliovirus serotypes of HEV typed by partial VP1 sequencing during the years 2000 to 2007. CV, coxsackievirus; E, echovirus; EV, enterovirus.

View this table: [in this window] [in a new window]

TABLE 2. Human enterovirus isolates typed as EV73 to EV102 by partial VP1 sequencing

As judged by the partial VP1 sequences, 37 isolates subjected to typing as NPEV were actually human rhinoviruses (HRV). The approximately 350-nucleotide-long sequences were not regarded as sufficient for the exact typing of HRV, but they were adequate enough to assign all of these isolates to species HRV-A. Besides being successful in amplifying HEV and HRV, the primers 222 and 292 also detected bovine enteroviruses (BEV). Altogether, 81 viruses isolated in L20B cells from environmental specimens collected in Finland, Croatia, Slovakia, and Egypt were classified as BEV. The partial VP1 nucleotide identities between the typed isolates and the BEV sequences in GenBank varied from 73 to 88%, confirming the species identification, while no serotype assignment was attempted.

In conclusion, molecular typing by partial VP1 sequencing was reliable and significantly shortened the hands-on time in routine HEV typing. Altogether, 1,121 HEV isolated in a variety of cell lines from diverse clinical and environmental specimens were successfully typed. The typed isolates included 48 of the 59 traditional NPEV serotypes and also 8 new types, which would have remained untypeable by neutralization. We believe that in our isolate collection no HEV remained untyped. One primer pair, 222 and 292, amplified almost all HEV isolates, and all the remaining ones were amplified by using primers 040, 011, and 012. Selected viruses that produced a cytopathic effect in enterovirus-accessible cells but were negative with both sets of VP1 primers were subsequently shown to be negative with primers from the conserved regions in the 5' nontranslating region (2), as well. Some of the latter isolates were further typed as adenoviruses or parechoviruses.

Nucleotide sequence accession numbers. The accession numbers for the sequences deposited in GenBank are EU481511 to EU481525.

 
The Regional Reference Laboratory work is supported by the WHO.

We gratefully acknowledge the National Polio Laboratories in Sweden, Denmark, Norway, Iceland, Estonia, Latvia, Lithuania, Austria, the Czech Republic, Croatia, Slovakia, Slovenia, Egypt, and Russia and the virological laboratories in Finland for providing us with enterovirus isolates and M. Steven Oberste, CDC, Atlanta, GA, for sharing the method with us before its publication and for help in the beginning. The expertise of Pia Laine in the validation process and the excellent technical assistance of Päivi Hirttiö are greatly appreciated.

 
* Corresponding author. Mailing address: Enterovirus Laboratory, Department of Viral Diseases and Immunology, National Public Health Institute (KTL), Mannerheimintie 166, 00300 Helsinki, Finland. Phone: 358 9 47448490. Fax: 358 9 4744 8355. E-mail: soile.blomqvist{at}ktl.fi

Published ahead of print on 7 May 2008.

Top ABSTRACT TEXT REFERENCES

 

1
1. Arola, A., J. Santti, O. Ruuskanen, P. Halonen, and T. Hyypiä. 1996. Identification of enteroviruses in clinical specimens by competitive PCR followed by genetic typing using sequence analysis. J. Clin. Microbiol. 34:313-318.[Abstract]
2
2. Blomqvist, S., A. Skyttä, M. Roivainen, and T. Hovi. 1999. Rapid detection of human rhinoviruses in nasopharyngeal aspirates by a microwell reverse transcription-PCR-hybridization assay. J. Clin. Microbiol. 37:2813-2816.[Abstract/Free Full Text]
3
3. Caro, V., S. Guillot, F. Delpeyroux, and R. Crainic. 2001. Molecular strategy for ‘serotyping’ of human enteroviruses. J. Gen. Virol. 82:79-91.[Abstract/Free Full Text]
4
4. Casas, I., G. F. Palacios, G. Trallero, D. Cisterna, M. C. Freire, and A. Tenorio. 2001. Molecular characterization of human enteroviruses in clinical samples: comparison between VP2, VP1, and RNA polymerase regions using RT nested PCR assays and direct sequencing of products. J. Med. Virol. 65:138-148.[CrossRef][Medline]
5
5. Hovi, T., M. Stenvik, and M. Rosenlew. 1996. Relative abundance of enterovirus serotypes in sewage differs from that in patients: clinical and epidemiological implications. Epidemiol. Infect. 116:91-97.[Medline]
6
6. Ishiko, H., Y. Shimuda, M. Yonaha, O. Hashimoto, A. Hayashi, K. Sakae, and N. Takeda. 2002. Molecular diagnosis of human enteroviruses by phylogeny-based classification by use of the VP4 sequence. J. Infect. Dis. 185:744-754.[CrossRef][Medline]
7
7. Jacques, J., H. Moret, D. Minette, N. Leveque, N. Jovenin, G. Deslee, F. Lebargy, J. Motte, and L. Andreoletti. 2008. Epidemiological, molecular and clinical features of enterovirus respiratory infections in French children between 1999 and 2005. J. Clin. Microbiol. 46:206-213.[Abstract/Free Full Text]
8
8. Khetsuriani, N., A. LaMonte-Fowlkes, M. S. Oberste, and M. A. Pallansch. 2006. Enterovirus surveillance---United States. 1970-2005. Morb. Mortal. Wkly. Rep. 55(SS08):1-20.[Medline]
9
9. Nasri, D., L. Bouslama, S. Omar, H. Saoudin, T. Bourlet, M. Aouni, B. Pozzetto, and S. Pillet. 2007. Typing of human enterovirus by partial sequencing of VP2. J. Clin. Microbiol. 45:2370-2379.[Abstract/Free Full Text]
10
10. Norder, H., L. Bjerregaard, L. Magnius, B. Lina, M. Aymard, and J. J. Chomel. 2003. Sequencing of ‘untypable’ enteroviruses reveals two new types, EV-77 and EV-78, within human enterovirus type B and substitutions in the BC loop of the VP1 protein for known types. J. Gen. Virol. 84:827-836.[Abstract/Free Full Text]
11
11. Oberste, M. S., K. Maher, D. R. Kilpatrick, and M. A. Pallansch. 1999. Molecular evolution of the human enteroviruses: correlation of serotype with VP1 sequence and application to picornavirus classification. J. Virol. 73:1941-1948.[Abstract/Free Full Text]
12
12. Oberste, M. S., K. Maher, M. R. Flemister, G. Marchetti, D. R. Kilpatrick, and M. A. Pallansch. 2000. Comparison of classic and molecular approaches for the identification of untypeable enteroviruses. J. Clin. Microbiol. 38:1170-1174.[Abstract/Free Full Text]
13
13. Oberste, M. S., W. A. Nix, K. Maher, and M. A. Pallansch. 2003. Improved molecular identification of enteroviruses by RT-PCR and amplicon sequencing. J. Clin. Virol. 26:375-377.[CrossRef][Medline]
14
14. Palacios, G., I. Casas, A. Tenorio, and C. Freire. 2002. Molecular identification of enterovirus by analyzing a partial VP1 genomic region with different methods. J. Clin. Microbiol. 40:182-192.[Abstract/Free Full Text]
15
15. Simmonds, P., and J. Welch. 2006. Frequency and dynamics of recombination within different species of human enteroviruses. J. Virol. 80:483-493.[Abstract/Free Full Text]
16
16. Smura, T. P., N. Junttila, S. Blomqvist, H. Norder, S. Kaijalainen, A. Paananen, L. O. Magnius, T. Hovi, and M. Roivainen. 2007. Enterovirus 94, a proposed new serotype in human enterovirus species D. J. Gen. Virol. 88:849-858.[Abstract/Free Full Text]
17
17. Smura, T., S. Blomqvist, A. Paananen, T. Vuorinen, Z. Sobotova, V. Bubovica, O. Ivanova, T. Hovi, and M. Roivainen. 2007. Enterovirus surveillance reveals proposed new serotypes and provides new insight into enterovirus 5'-untranslated region evolution. J. Gen. Virol. 88:2520-2526.[Abstract/Free Full Text]
18
18. Stanway, G., F. Brown, P. Christian, T. Hovi, T. Hyypiä, A. M. Q. King, N. J. Knowles, S. M. Lemon, P. D. Minor, M. A. Pallansch, A. C. Palmenberg, and T. Skern. 2005. Family Picornaviridae, p. 757-778. In C. M. Fauquet, M. A. Mayo, J. Maniloff, U. Desselberger, and L. A. Ball (ed.), Virus taxonomy: eighth report of the International Committee on Taxonomy of Viruses. Elsevier/Academic Press, London, United Kingdom.

---

Journal of Clinical Microbiology, July 2008, p. 2410-2413, Vol. 46, No. 7
0095-1137/08/$08.00+0     doi:10.1128/JCM.00313-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

This article has been cited by other articles:

• Blomqvist, S., Savolainen-Kopra, C., Paananen, A., Hovi, T., Roivainen, M. (2009). Molecular characterization of human rhinovirus field strains isolated during surveillance of enteroviruses. J. Gen. Virol. 90: 1371-1381 [Abstract] [Full Text]  

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Blomqvist, S. Articles by Roivainen, M. Search for Related Content PubMed PubMed Citation Articles by Blomqvist, S. Articles by Roivainen, M.